Zobrazeno 1 - 10
of 46
pro vyhledávání: '"W R Hiatt"'
Publikováno v:
Interventionelle Radiologie Scan. :26-28
Autor:
W R Hiatt
Publikováno v:
Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie. :105-105
Publikováno v:
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 47(5)
Autor:
W R, Hiatt
Publikováno v:
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 42
Publikováno v:
The Cochrane database of systematic reviews. (4)
Omega-3 fatty acids are established as being effective in the treatment and prevention of coronary artery disease. It is possible that they may also benefit people with peripheral arterial disease, since the pathogenesis of the two conditions is simi
Autor:
L, Norgren, W R, Hiatt, J A, Dormandy, M R, Nehler, K A, Harris, F G R, Fowkes, R B, Rutherford
Publikováno v:
International angiology : a journal of the International Union of Angiology. 26(2)
Autor:
T, Sommerfield, W R, Hiatt
Publikováno v:
The Cochrane database of systematic reviews. (3)
Omega-3 fatty acids are established as being effective in the treatment and prevention of coronary artery disease. It is possible that they may also benefit people with peripheral arterial disease, since the pathogenesis of the two conditions is simi
Autor:
W R, Hiatt, J G, Regensteiner, M A, Creager, A T, Hirsch, J P, Cooke, J W, Olin, G N, Gorbunov, J, Isner, Y V, Lukjanov, M S, Tsitsiashvili, T F, Zabelskaya, A, Amato
Publikováno v:
The American journal of medicine. 110(8)
We tested the hypothesis that propionyl-L-carnitine would improve peak walking time in patients with claudication. Secondary aims of the study were to evaluate the effects of propionyl-L-carnitine on claudication onset time, functional status, and sa
Autor:
W R, Hiatt
Publikováno v:
International journal of clinical practice. Supplement. (119)
The goals of treatment in intermittent claudication are to modify cardiovascular risk factors and to reduce claudication pain, increase walking distance and improve quality of life. Walking distance in intermittent claudication can be improved both b
Publikováno v:
Vascular medicine (London, England). 5(4)
Peripheral arterial disease (PAD) is associated with metabolic derangements and accumulation of the common 4977 bp mitochondrial DNA (mtDNA) deletion mutation. The current study was undertaken to test the hypothesis that PAD is associated with multip